Member Info for Globex

At this point you'd feel nervous even ordering from them in case it doesn't arrive before the whole lot keels over, let alone investing in them.

Btw user EquityDevelpmen is paid for by company to promote the stock. He should be disclosing that.

Fact they need to pay someone to write nice things about them on here another red flag.

Their now big now problem is zero USP. Generic versions of their products now readily available in B&Q, Wickes etc. There is another company on the premium end of this market whose name escapades me as I could not find taps more uninteresting, but even I'm aware of it as it advertises absolutely everywhere. Whereas these guys just don't seem to have equivalent marketing savvy - or budget given that debt burden. Can't see any kind of investment case here - and god knows you need it to put money into something as boring as taps.

On the one hand it's good as US primary listing a certainty now where fintechs tend to attract higher valuation.

One other it's less good (depending on your point of view) that the voting rights of Käärmann's shares extended for many years. A majority voted for it but his co-founder not happy - he makes a decent case that vote on this issue was a bit lumped in with US listing vote, and that it goes back on Käärmann's original pledge to reduce his voting rights to equal those of regular shareholders.

Boohoo appears to be on brink, read across to other debt burdened UK retailers

Same with my broker - split into two, but still paid in full on 25th.

Seems HSBC may have been yanking someone's chain there.

Time for the market to respect this diamond with a proper valuation

Guardian quotes EU side saying "It is agreed that we have 15% for pharmaceuticals" which seems specific enough, but then Trump seems to contradict that, all typically ambiguous at the moment. They'll surely give more detail before market open.

https://www.theguardian.com/us-news/2025/jul/27/eu-delegation-poised-for-trump-trade-talks-in-scotland

Https://www.cnbc.com/2025/07/27/trump-european-union-eu-trade-tariffs.html

15% tariffs including pharmaceuticals - expect relief rally in sector tomorrow.

Actually you are wrong. These are all definitely index funds, ie following an index. If they use derivatives as part of their plumbing that does not mean they are not indexes. You only have to look at the descriptions for each, they all say so.

Schwab Fundamental International Small Company Index ETF = RAFI Fundamental High Liquidity Developed ex US Small Index

iShares MSCI United Kingdom Small-Cap ETF = MSCI United Kingdom Small-Cap Index

Schwab International Small-Cap Equity ETF = FTSE Developed Small Cap ex US Liquid Index

Those are all index funds, they are just all passively following indexes. They buy/sell neutrally based on any given company's relative size in any index. iShares(Blackrock) are largest index fund providers globally, so they will always put through most volume. Honestly not worth overthinking or spending any time on.

This must be the lowest effort management team on whole of LSE.

Notable to see that sell today at 10p just before results. Insider no doubt, absolutely typical of unregulated aim.

Bet they now take this private.

Starting to see this separate out from the usual read across from lower grade names and rightly so, always seemed absurd to me it got lumped in with some of these lesser btc treasuries.

Have to agree with you about AEG - and BMV of course have no doubt some magic awaits us here

It's just ebbing and flowing during thin summer trading volume. We are still way under the radar now but it's easy to see how that changes once newsflow starts coming - in particular once the prospectus is published, institutional investors and the £10m+ can be onboarded.

It is interesting to note that no other stock with a bitcoin treasury comes close to being priced this low.

Then you start to add the overall asset value into the mix too, the potential here speaks for itself.

Yes it's a nonsense, all part of the grift. Matches a certain poster on here posting in riddles, writer probably came across it reading stock of Free Association Books and inadvertently shoehorned it in.

Seeing Hamak price action a clear demonstration we are in exactly the right play here. Gold & btc in the one vehicle makes for an unstoppable combination. What market is grossly underrating with Bluebird vs Hamak in my view is that here we have key elements you don't elsewhere - raising at a premium, being first movers on btc/gold, mining in a safe jurisdiction - and the best part is rather than just a an explorer, we are actually in production and profitable.

Buying here, with the assets they have compared to market cap, together with crypto treasury strategy where they have actively bought, rather than just talking about it, you don't see opportunities like this every day.

From latest results published in May:

•EPRA Net Tangible Assets per share 567p

This takes into account debt. So at today's close of ~355p, it's valued at only ~62% of tangible NAV.

Across sector, it simply does not get much cheaper than this. Good enough for me.

As for gearing, LTV here actually lower than closest peer Landsec.

Btw Finley1 I agree encouraging to see these director purchases, right up to chair level. All too often you see plc management get rewarded with free shares, so has to instil confidence that here they're spending their own money on these positions.